[ad_1]
A reassuring commitment by US President Donald Trump to NATO at the top of the defense alliance also helped to calm European markets. However, observers have warned that the optimistic sentiment may be short-lived in the face of heightened tensions. The focus has also been on the earnings season, with investors picking up the first half of the year in the local market.
The SMI ended the month up 1.56% to settle at 8,818.19 points just below the daily maximum of 8821 meters. The 30-share Swiss Leader Index (SLI) rose 1.09% to 1,450.76 points and the Swiss Performance Index (SPI) rose 1.33% to 10,563.57.
On Thursday, pharmaceutical heavyweights Novartis (+ 4.1%) and Roche (+ 3.2%), which had been rather weak since the beginning of the year, favored investors. Among other things, the market has reported positive news from businesses lately. Berenberg Research has certified Roche in a progress study with the pipeline and recommended that the securities be purchased new. Roche also announced Thursday that it had received a request for US approval for an extension of leukemia drug approval.
Meanwhile, Vifor Pharma (+ 3.2%) continued its steady progression since the beginning of the month, with new records.
Cyclical stocks recorded stronger gains, such as Dufry (+ 2.4%) and Sika (+ 1.2%). On the other hand, ABB (+ 0.2%) or LafargeHolcim (+ 0.2%) outperformed the market. The shares of the Franco-Swiss cement plant were selected by cautious analysts. According to a comment, Goldman Sachs' experts expect persistent headwinds from emerging markets and UBS experts also fear a pressure on margins, particularly in Africa and the Middle East.
Lower values also include bank stocks: UBS (+0, 5%) finished the day up, CS barely changed, and Julius Baer's private banking stocks (-1.8%) been among the few losers among the blue chips.
The shares of the Asset Manager Partners group (-0.6%) also closed the month after the presentation of the half-year figures. The private equity specialist has responded very little to the high expectations of analysts, which constitutes an "unusual experience" for the market, commented the ZKB.
Financial markets were also under pressure on the whole market. Substantial expenses were incurred by Bank Vontobel's shares (-5.1%). Analysts at US bank Citigroup lowered their rating for Vontobel shares to "neutral" previously "buy", highlighting in particular the share price, which has risen sharply since the beginning of the year. year.
The shares of Bank Valiant (-4.8%) and Vaud Cantonal Bank (-3.1%) were considered underperforming in a sector study of Credit Suisse. The levies also suffered LLB shares (-1.1%), the Liechtenstein Institute had announced Thursday morning, a decline in profits in the semester.
Significantly in the most closed, however, the title of the industrial company Bossard (+ 6.7%), the expected number for the first half. In addition, the semi-annual figures of the DSKH trading company (+ 2.3%) were also positively received. The shares of the VAT vacuum valve manufacturer (+ 2.9%) benefited from a purchase recommendation from the British bank HSBC
tp / cf
(AWP) [19659013]
[ad_2]
Source link
